Source:http://linkedlifedata.com/resource/pubmed/id/11915739
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2002-3-27
|
pubmed:abstractText |
A 75-year-old male patient was hospitalized for examination of abdominal trouble. Endoscopic examination simultaneously revealed 0-I pl + II c esophageal cancer and type 3 gastric cancer. Endoscopic treatment is impossible to resect the lesion completely. It is difficult for the patient to undergo an operation because he has suffered from a cardiac infarction and pulmonary trouble. Thus, gastric cancer was treated by chemotherapy and esophageal cancer by concurrent chemoradiotherapy with chemotherapy used for gastric cancer. Chemotherapy consisted of CDDP and TS-1 every 4 weeks. TS-1 (100 mg/day) was administered on days 1 to 21, and CDDP (70 mg/m2) was infused for 24 hours on day 8. Radiotherapy (5 days/week) at 2 Gy/day was concurrently started from the beginning of chemotherapy. At day 8 in the 2nd course of chemotherapy, leucocytopenia of grade 2 and appetite loss of grade 3 (NCI-CTC) were seen. Chemoradiotherapy was then suspended for one week. After recovery from toxicity, treatment was continued for a week. A total of 64 Gy was administered. After treatment, endoscopic examination with biopsy revealed the disappearance of gastric and esophageal cancer.
|
pubmed:language |
jpn
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations,
http://linkedlifedata.com/resource/pubmed/chemical/Oxonic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Pyridines,
http://linkedlifedata.com/resource/pubmed/chemical/S 1 (combination),
http://linkedlifedata.com/resource/pubmed/chemical/Tegafur
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0385-0684
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
455-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11915739-Aged,
pubmed-meshheading:11915739-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11915739-Carcinoma, Squamous Cell,
pubmed-meshheading:11915739-Cisplatin,
pubmed-meshheading:11915739-Drug Administration Schedule,
pubmed-meshheading:11915739-Drug Combinations,
pubmed-meshheading:11915739-Esophageal Neoplasms,
pubmed-meshheading:11915739-Humans,
pubmed-meshheading:11915739-Male,
pubmed-meshheading:11915739-Neoplasms, Multiple Primary,
pubmed-meshheading:11915739-Oxonic Acid,
pubmed-meshheading:11915739-Pyridines,
pubmed-meshheading:11915739-Remission Induction,
pubmed-meshheading:11915739-Stomach Neoplasms,
pubmed-meshheading:11915739-Tegafur
|
pubmed:year |
2002
|
pubmed:articleTitle |
[Complete response in a case of simultaneous esophageal and gastric cancer treated by combined radiotherapy and chemotherapy of TS-1 and CDDP].
|
pubmed:affiliation |
Dept. of Gastroenterology, Nagoya National Hospital.
|
pubmed:publicationType |
Journal Article,
English Abstract,
Case Reports
|